Trial intelligence / Profile preview

Bendamustine in advanced ovarian cancer

NCT00867503Phase 2Completed

Sponsor
University of Arizona
Start
Feb 2009
Primary completion
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bendamustine in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal serous papillary carcinoma (PSPCP), sponsored by University of Arizona. Started Feb 2009; status: completed.

02

Drugs

bendamustine
03

Conditions

ovarian cancerfallopian tube cancer (PFTC)primary peritoneal serous papillary carcinoma (PSPCP)

Beyond the preview

Go deeper on NCT00867503.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00867503.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call